Milagen
Our mission is to discover, develop and commercialize easy to use, non invasive, in vitro diagnostic products designed to fulfill unmet clinical needs in the prevention, detection, diagnosis and management of major cancers.
Read MoreMercator MedSystems
Mercator MedSystems, Inc., is a medical technology company focused on the treatment of peripheral artery disease using its catheter-guided, micro-infusion systems for site-specific, non-systemic delivery of therapeutic agents directly across any blood vessel.
Read MoreLumiphore Inc.
Develops bi-functional chelators for biomedical applications.
Read MoreLucira Health (formerly DiAssess Inc)
Lucira Health is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the…
Read MoreIQ Biosciences
iQ Biosciences provides focused research support to the pharmaceutical, biotechnology, and diagnostic industries in the form of intelligent research services and quality biospecimens
Read MoreIntegrated Analytical Solutions
Expert bioanalytical and drug metabolism services
Read MoreiKnowMed, Inc.
iKnowMed, Inc. develops a web-based oncology specific electronic medical records (EMR) system that replaces paper charts to provide clinical patient information for physicians.
Read MoreIndee Labs
Indee Labs is developing hardware for gene delivery. Our hardware is uniquely positioned for the efficient development and scalable manufacture of gene-modified cell therapies such as chimeric antigen receptor T cells.
Read MoreGrifols Diagnostic Solutions Inc
Grifols produces essential plasma medicines for patients to treat rare, chronic and, at times, life-threatening conditions.
Read MoreEureka Therapeutics Inc
Utilizing our antibody drug discovery and engineering technologies, we are advancing safe and effective therapies for targeting previously inaccessible cancer antigens. We have built an early stage pipeline of innovative drugs, with the most advanced candidates at pre-clinical stage.
Read More